at are under investigation in this trial.
The baseline frequency and severity of anginal episodes are established as a first step for all study subjects. Next, all subjects receive a series of subcutaneous injections (needle shots, typically delivered under the skin in the arm, thigh or abdomen) of a commercially produced protein (granulocyte colony stimulating factor). The protein helps to release CD34+ stem cells (also known as endothelial progenitor cells) from a subject’s bone marrow into the bloodstream.
Then, investigators use a cell separation system, similar to the automated systems that are used with people who donate specific blood components such as platelets or red blood cells, to collect from the subject’s bloodstream, an enriched preparation of cells that contain CD34+ stem cells. When this process, known as apheresis, is complete, technologists further process the collected stem cells with Baxter’s ISOLEX 300i Magnetic Cell Selection System, currently approved for use with cancer patients, to select the subject’s CD34+ stem cells for use in this investigational therapy.
Schaer then uses a catheter-based, non-surgical system to map the patient’s heart three-dimensionally to identify the damaged areas into which the stem cells would be injected. "This targeted approach increases the treatment's effectiveness by delivering the stem cells exactly where they are needed." Schaer uses the Johnson & Johnson’s NOGA XP Cardiac Navigation System to identify Ischemic but viable regions of the heart as targets for cell delivery. The researchers then use a special investigational catheter that functions like a "global positioning system" to precisely deliver CD34+ cells, or placebo, into the areas of the heart that have been identified as having poor blood flow.
Subjects are randomly selected to receive either one of two dosing levels of CD34+ stem cells, or placebo. Rush researchers will conduct follow-up examinations for 12
'"/>Page: 1 2 3 Related medicine news :1.
Potential New Cancer Gene Identified2.
Lack of Smell And Its Potential Risks 3.
New Blood Thinner Pill - First Potential Alternative to Warfarin in 50 years4.
The Potential Of Cadaver Transplantation Programme In India5.
Another Potential Of Stem Cells Discovered: Used For Growing Cartilage6.
Yoga Guru Ramdev Invited to Tap Ayurveda Potential by Jharkhand Govt 7.
A Protein In Yoghurt Has The Potential To Fight E. coli8.
Gold Therapy- A Potential Treatment For Autoimmune Diseases9.
Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains10.
Potential Benefits Of New Nanotechnology11.
Hormone Can Foretell Presence Of Potentially Fatal Pulmonary Hypertension